Immunotherapy in pancreatic cancer treatment: a new frontier
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-10-17 / Therap Adv Gastroenterol 2017 Jan;10(1):168-194Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-09-29 / Cancer Immunol. Immunother. 2016 12;65(12):1499-1509Induction of Immune Response after Allogeneic Wilms‘ Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse
/in Acute Leukemia, Dendritic Cells, International Publications /von 2016-09-12 / Biol. Blood Marrow Transplant. 2016 12;22(12):2149-2154A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):64Advances and challenges: dendritic cell vaccination strategies for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-08-10 / Expert Rev Vaccines 2017 01;16(1):27-36Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-07-29 / Ophthalmology 2016 10;123(10):2265-7Immunotherapy for the Treatment of Urothelial Carcinoma
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-07-25 / J Urol 2017 01;197(1):14-22Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis
/in Dendritic Cells, International Publications, NSCLC /von 2016-07-22 / Cancer Immunol. Immunother. 2016 09;65(9):1099-111Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-07-21 / Onco Targets Ther 2016;9:4441-51
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de